Suppr超能文献

[铁调素,铁吸收的负调节因子]

[Hepcidin, the negative regulator of iron absorbtion].

作者信息

Balogh Adám, Derzbach László, Vásárhelyi Barna

机构信息

Semmelweis Egyetem, Altalános Orvostudományi Kar, I. Gyermekgyógyászati Klinika, Budapest.

出版信息

Orv Hetil. 2004 Jul 25;145(30):1549-52.

Abstract

The task of the iron regulatory system is to balance between iron-stores and iron-consumption. Recently the predominant negative regulator of iron absorbtion in the small intestine and iron release from macrophages has been discovered. That is the hepcidin. Hepcidin, the 25-amino acid peptide produced by the hepatocytes, may be a new mediator of innate immunity and the long-sought iron regulatory hormone. Hepcidin is an acute phase peptide, its production is increased in inflammation and in iron overload. According to evidence obtained in mouse models hepcidin decreases the iron absorbtion in the small intestine and inhibits iron release from macrophage and iron transport across placenta. Hereby the hepcidin decreases the plasma iron level. The exact patomechanism of hepcidin is not clarified and its receptor is still unknown. The discovery of hepcidin and its role in iron metabolism could lead to new diagnostic possibilities on the field of hemochromatosis, other iron-regulatory diseases and anaemia of inflammation.

摘要

铁调节系统的任务是在铁储存和铁消耗之间保持平衡。最近,已发现小肠中铁吸收和巨噬细胞中铁释放的主要负调节因子。即铁调素。铁调素是由肝细胞产生的一种含25个氨基酸的肽,可能是天然免疫的新介质以及长期寻找的铁调节激素。铁调素是一种急性期肽,其生成在炎症和铁过载时增加。根据在小鼠模型中获得的证据,铁调素降低小肠中的铁吸收,并抑制巨噬细胞中的铁释放以及铁穿过胎盘的转运。由此,铁调素降低血浆铁水平。铁调素的确切发病机制尚未阐明,其受体仍然未知。铁调素的发现及其在铁代谢中的作用可能会在血色素沉着症、其他铁调节疾病和炎症性贫血领域带来新的诊断可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验